US Stock MarketDetailed Quotes

ORMP Oramed Pharmaceuticals

Watchlist

2.370
0.0000.00%

Close Nov 29 13:00 ET

2.370
0.0000.00%

Post 15:16 ET

95.54MMarket Cap21.55P/E (TTM)

Oramed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oramed Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2022/Q3	-- / 687.000K	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 250.000K	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2022/Q3-- / 687.000K--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 250.000K--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Oramed Pharmaceuticals Earnings Reports

Oramed Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7 16:10 ET

Oramed Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 14 16:13 ET

Oramed Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

May 9 17:06 ET

Oramed Pharmaceuticals | 10-K: FY2023 Annual Report

Mar 6 17:06 ET

Analyst Rating

Updated: Sep 9, 2024

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall